India national influenza programme: influenza factsheet 2021

21 Basic information (2021) Total population 1,358,652,1151 Children <5 years 147,826,6671 Under-5 mortality rate (per 1000 live births) 39.11 Life expectancy at birth (years) 68.82 Provinces/divisions/regions/zones 36 Districts 712 Total health expenditure (% of GDP) 3.91 Income level (World Bank) Lower middle3 1https://www.who.int/southeastasia/health-topics/immunization 2https://www.who.int/gho/publications/world_health_statistics/2020/en/ 3https://data.worldbank.org/ Influenza-like illness (ILI) surveillance Type of ILI surveillance Universal/non-sentinel/national surveillance Sites involved in ILI surveillance Hospitals (outpatients) Clinical case definition used for ILI case ascertainment WHO 2014 Is laboratory confirmation sought in ILI cases? Yes, a proportion of ILI cases are laboratory tested Number of ILI surveillance sites All 'P Form' reporting sites under the integrated disease surveilance programme (IDSP) Number of states/districts covered by the surveillance system 36 % of the population covered by the surveillance system 100 Denominator used for ILI surveillance Number of outpatient visits Reporting frequency to the national level Weekly How are the data reported Aggregated reporting Form of the reporting tool Electronic Severe acute respiratory infection (SARI) surveillance Type of SARI surveillance Universal/non-sentinel/national surveillance Sites involved in SARI surveillance Hospitals (inpatients) INDIA National Influenza Programme 22 Clinical case definition used for SARI case ascertainment WHO 2014 Is laboratory confirmation sought in SARI cases? Yes, all SARI cases are tested Number of SARI surveillance sites All 'P Form' reporting sites under integrated disease surveilance programme (IDSP) Number of states/districts covered by the surveillance system 36 % of the population covered by the surveillance system 100 Denominator used for SARI surveillance Number of inpatient visits Reporting frequency to the national level Weekly How are the data reported Aggregated reporting Form of the reporting tool Electronic Intensive care unit (ICU) surveillance Does the country have surveillance for influenza in the ICU? No Is laboratory confirmation sought in ICU cases? N/A Is case-based information collected? N/A Death surveillance Is timely all-cause mortality data (i.e. within one month) available in the country? No Virological surveillance system Does the country have virological surveillance? Yes Type of virological surveillance If sentinel, number of sites involved Sentinel 54 Is epidemiological case information collected? If yes, are the laboratory results linked with epidemiological data? Yes Yes Average number of virological samples processed per week 270 Are samples processed from ILI or SARI surveillance systems? Yes, from both sources Does the country have virus isolation capacity? Yes Does the country have RT-PCR capacity? % laboratories that perform RT-PCR % RT-PCR laboratories that report to the NIC Yes 100% 100% Does the country use rapid diagnostic testing for influenza surveillance? No Does the country have genomic sequencing capacity? Yes Does the country test for other respiratory viruses? Yes 23 Number and percentage of specimens positive for influenza and subtypes, 2019–2021 Source: GISRS/ FLUMART (http://apps.who.int/flumart/) National Influenza Centre Does the country have a National Influenza Centre (NIC) or national laboratory? Yes, NIC (established 1980) Assays routinely performed at the NIC or national laboratory PCR, antiviral susceptibility testing Does the NIC have Virus isolation capability Antigenic characterisation capability Antiviral susceptibility testing capability Sequencing capability Yes Yes Yes Yes Does the NIC test for other respiratory viruses? Yes – Respiratory Syncytial Virus (RSV) , Human metapneumovirus (hMPV), coronavirus, parainfluenza, rhinovirus, adenovirus, bocavirus Does the country have a quality control plan? Yes Does the country follow national biosafety and biosecurity policy guidelines? Yes Does the country forward samples to a WHO CC? Yes – United States Centers for Disease Control and Prevention (US CDC)-Atlanta, The National Institute of Infectious Diseases (NIID), Tokyo- Japan Frequency of sample shipment? Twice per year Reporting Frequency of national reports Monthly Are epidemiological and virological data integrated? No Reported via a website? Yes – https://ncdc.gov.in/showfile. php?lid=280 24 Does the country report to the FluID? Year of beginning of reporting Frequency of reporting No NA NA Does the country report to the FluNet? Year of beginning of reporting Frequency of reporting Yes 2011 Weekly Are there fixed outbreak thresholds? No Level at which data are stored, managed and analysed Both at national and sub-national levels Has formal training on data reporting and analysis been provided to epi and lab staff? If yes, when? Has a training session been planned? If yes, when? Yes October 2017 No, 2022 Vaccination Does the country have a formal seasonal influenza vaccination policy? Yes Has seasonal influenza been introduced in the public sector? Year introduced Recommended risk groups Vaccination period Vaccine hemisphere Vaccine type Yes 2015 Health care workers working in emergencies, ICU, RRTs, laboratory staff and drivers involved in handling influenza patients Winter Northern Quadrivalent Is seasonal influenza offered in the private sector? Only offered to particular risk groups. Vaccination period Vaccine hemisphere Vaccine type Yes No Quadrivalent Is vaccine offered to Hajj and Umrah pilgrims? Yes, through the national programme Vaccine production capacity Yes Pandemic preparedness Does the country have a National Influenza Pandemic Preparedness Plan? Year developed Year last updated Yes 2009 2019 (draft) Has the country performed simulation exercises? Yes – table top Are there laboratory testing strategies in place for different phases of an influenza pandemic? Yes Are there surge capacity plans? Yes – included in the national influenza pandemic preparedness plan Does the pandemic preparedness plan include a detailed National Pandemic Vaccine Deployment Plan? Are there priority groups for pandemic vaccinations? Yes –